Medicinal Products

Triumeq

Name Triumeq
Active Substance dolutegravir / abacavir / lamivudine
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code J05AR13
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Prezentacija za zdravstvene radnike, verzija 3

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/triumeq

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o oštećenjima neuralne cijevi u novorođenčadi čije su majke bile izložene dolutegraviru u trenutku začeća 11.06.2018 ViiV Healthcare
Back